New CRM launches
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific announces CE-mark approval of the Cognis cardiac resynchronization therapy defibrillator (CRT-D) and the Teligent ICD Jan. 22. The company says the devices, for which a full rollout in international markets is planned in the second quarter, are among the smallest and thinnest implantable defibrillators available, at 32.5 cc and 31.5 cc, respectively. Both products are pending FDA approval, with a U.S. launch expected in the second half of 2008, the firm says (1"The Gray Sheet" Oct. 29, 2007, p. 16)